Great West Life Assurance CO Regeneron Pharmaceuticals, Inc. Transaction History
Great West Life Assurance CO
- $58 Billion
- Q4 2024
A detailed history of Great West Life Assurance CO transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 120,865 shares of REGN stock, worth $85.4 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
120,865
Previous 126,196
4.22%
Holding current value
$85.4 Million
Previous $133 Million
35.25%
% of portfolio
0.15%
Previous 0.23%
Shares
31 transactions
Others Institutions Holding REGN
# of Institutions
1,489Shares Held
85.7MCall Options Held
1.53MPut Options Held
1.44M-
Vanguard Group Inc Valley Forge, PA9.29MShares$6.56 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.97 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.06MShares$4.99 Billion0.41% of portfolio
-
State Street Corp Boston, MA4.83MShares$3.42 Billion0.14% of portfolio
-
Capital International Investors Los Angeles, CA4.74MShares$3.35 Billion0.66% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $75.8B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...